BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aragon Surgical, Inc. IntelliSeal OS12 Receives FDA 510(k) Clearance


11/18/2008 6:20:48 AM

PALO ALTO, Calif.--(BUSINESS WIRE)--Aragon Surgical, Inc., a venture backed emerging medical device company, announced today that it has received FDA clearance for the IntelliSeal OS12, the first instrument in their platform of RF products that will cross a broad array of specialties. The OS12 was designed with gynecologists for use in abdominal (“open”) hysterectomy.

“We are very excited about introducing this unique surgical device to gynecologists,” said Roseanne Varner, President and CEO of Aragon Surgical. “Feedback from both physician users and potential users on the obvious advantages of this device has been very positive.”

The IntelliSeal™ product line utilizes proprietary TissueSense™ technology in all of their electrosurgical instruments and systems. This unique energy delivery platform serves as the foundation for several open and laparoscopic surgical instruments. All IntelliSeal electrosurgical systems are designed to reduce operative time and improve patient safety.

Aragon Surgical plans to introduce additional products that utilize their proprietary TissueSense™ technology in 2009.

About Aragon Surgical, Inc.

Located in Palo Alto, California, Aragon Surgical is a venture backed, market driven surgical device company that is developing and commercializing a variety of surgical instruments intended to reduce operative time and improve patient safety, benefiting both patients and surgeons. Aragon Surgical was founded in 2005 and is funded by Bay City Capital, Delphi Ventures, ONSET Ventures and Integral Capital Partners.

Contact:

Aragon Surgical, Inc. Christine L. Cunningham, 650-543-3100 Vice President of Marketing & Business Development CCunningham@AragonSurgical.com

Source: Aragon Surgical, Inc.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES